The illegal, unregulated, and dangerous influx of vaping devices from China sparked Senate bipartisanship this week, when the Senate Judiciary Committee hammered the task-force Joe Biden appointed to tackle the issue.

The Food and Drug Administration (FDA) authorizes the sale of 23 vaping devices. The Associated Press reports, however, that there are almost 10,000 different vapes sold across America –— many of which target children. According to the Director of the White House Office of National Drug Control Policy in President Barack Obama’s administration, “the use of disposable vapes by U.S. high school aged children has risen an incredible 1,336% since 2019. Most of these products, about 90%, come from China.” According to the FDA, the two most popular vapes in America, Elf Bar and Esco Bar, are both made in China.

Judiciary Chairman Sen. Dick Durbin (D., Ill.) highlighted Joe Biden’s administration’s regulatory failures, which have allowed for a Chinese-controlled vaping device black market, in Wednesday’s Judiciary hearings.

“You’ve completely fallen down on the job,” Durbin told officials from the FDA and from the Department of Justice (DOJ). “What in the hell have you been waiting for?”

Sen. John Cornyn (R., Texas) noted that some Chinese-manufactured vaping devices that are sold to American children are banned in China: “You can’t sell them in China but you can sell them in the United States and essentially victimize and addict our children,” Cornyn said, holding a Mike Tyson-branded vape that is manufactured in China.

Days before the hearing, the FDA and the DOJ announced plans to combat the industry’s pervasive targeting of children. A law enforcement veteran told the Reporter that such the joint FDA and DOJ task-force appointed to combat the vaping industry’s pervasive targeting of children is an “unserious” endeavor: “Putting the FDA in charge of dismantling Chinese organized crime is like putting Cub Scouts in charge of enforcing RICO statutes,” he said.

Illegal Chinese vapes are “100 percent contraband and you’re leaving it up to the FDA? Come on,” a drug policy expert told the Reporter.

A Senate source described the announcement from FDA and DOJ as a “last-ditch effort to show they’re doing something before the hearing,” and said that “Senators are not going to take this seriously. They’ve had years to fix this mess.”